Peptides may soon be easier to get amid RFK Jr's push, but experts warn of risks

The FDA is considering easing restrictions on peptides in a July meeting, influenced by Health and Human Services Secretary Robert F. Kennedy Jr.'s push for deregulation. Peptides, used for conditions like insomnia and obesity, face safety concerns despite their popularity among wellness influencers. Experts warn of risks due to limited FDA review.